News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,012 Results
Type
Article (1587)
Company Profile (11)
Press Release (71414)
Section
Business (31384)
Career Advice (54)
Deals (4634)
Drug Delivery (4)
Drug Development (7830)
Employer Resources (9)
FDA (1263)
Job Trends (1702)
News (43362)
Policy (2360)
Tag
Academia (151)
Accelerated approval (3)
Adcomms (1)
Allergies (14)
Alliances (2451)
ALS (13)
Alzheimer's disease (162)
Antibody-drug conjugate (ADC) (40)
Approvals (1368)
Artificial intelligence (26)
Autoimmune disease (24)
Automation (3)
Bankruptcy (12)
Best Places to Work (1622)
BIOSECURE Act (1)
Biosimilars (6)
Biotechnology (12)
Bladder cancer (38)
Brain cancer (3)
Breast cancer (91)
Cancer (711)
Cardiovascular disease (45)
Career advice (49)
Career pathing (1)
CAR-T (23)
CDC (1)
Cell therapy (72)
Cervical cancer (4)
Clinical research (7555)
Collaboration (95)
Compensation (79)
Complete response letters (5)
COVID-19 (180)
CRISPR (10)
C-suite (23)
Cystic fibrosis (28)
Data (1111)
Depression (14)
Diabetes (48)
Diagnostics (767)
Digital health (5)
Diversity, equity & inclusion (2)
Drug discovery (17)
Drug pricing (6)
Duchenne muscular dystrophy (61)
Earnings (29661)
Editorial (1)
Employer branding (1)
Employer resources (7)
Events (8688)
Executive appointments (26)
FDA (1806)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (10)
Funding (82)
Gene editing (22)
Generative AI (1)
Gene therapy (57)
GLP-1 (87)
Government (212)
Guidances (263)
Healthcare (2107)
HIV (5)
Huntington's disease (4)
IgA nephropathy (7)
Immunology and inflammation (26)
Immuno-oncology (7)
Indications (23)
Infectious disease (207)
Inflammatory bowel disease (21)
Influenza (13)
Intellectual property (7)
Interviews (3)
IPO (3459)
IRA (2)
Job creations (177)
Job search strategy (46)
JPM (2)
Kidney cancer (5)
Labor market (10)
Layoffs (25)
Leadership (1)
Legal (516)
Liver cancer (3)
Lung cancer (130)
Lymphoma (76)
Machine learning (2)
Management (3)
Manufacturing (35)
MASH (41)
Medical device (1780)
Medtech (1788)
Mergers & acquisitions (1271)
Metabolic disorders (159)
mRNA (5)
Multiple sclerosis (25)
NASH (2)
Neurodegenerative disease (32)
Neuropsychiatric disorders (13)
Neuroscience (310)
NextGen: Class of 2026 (457)
Non-profit (267)
Now hiring (1)
Obesity (65)
Opinion (6)
Ovarian cancer (21)
Pain (12)
Pancreatic cancer (23)
Parkinson's disease (29)
Partnered (2)
Patents (17)
Patient recruitment (24)
Peanut (7)
People (2305)
Pharmaceutical (3)
Pharmacy benefit managers (2)
Phase 1 (1833)
Phase 2 (3220)
Phase 3 (3106)
Pipeline (1789)
Policy (6)
Postmarket research (237)
Preclinical (571)
Prostate cancer (38)
Psychedelics (4)
Radiopharmaceuticals (29)
Rare diseases (113)
Real estate (218)
Recruiting (3)
Regulatory (2027)
Reports (10)
Research institute (148)
Resumes & cover letters (4)
Rett syndrome (5)
RSV (8)
Schizophrenia (34)
Series A (6)
Series B (4)
Service/supplier (1)
Sickle cell disease (14)
Special edition (4)
Spinal muscular atrophy (23)
Sponsored (3)
Startups (113)
State (1)
Stomach cancer (2)
Tariffs (1)
Vaccines (59)
Weight loss (31)
Women's health (9)
Worklife (1)
Date
Today (31)
Last 7 days (99)
Last 30 days (550)
Last 365 days (4387)
2026 (872)
2025 (4429)
2024 (4867)
2023 (5331)
2022 (7552)
2021 (6430)
2020 (6114)
2019 (5152)
2018 (3742)
2017 (3562)
2016 (2559)
2015 (3517)
2014 (2240)
2013 (1630)
2012 (1701)
2011 (1897)
2010 (1779)
Location
Africa (54)
Alabama (6)
Alaska (1)
Arizona (23)
Arkansas (1)
Asia (3793)
Australia (446)
California (1784)
Canada (407)
China (124)
Colorado (109)
Connecticut (115)
Delaware (76)
Europe (11109)
Florida (297)
Georgia (57)
Idaho (5)
Illinois (123)
India (10)
Indiana (84)
Iowa (1)
Japan (54)
Kansas (13)
Kentucky (4)
Louisiana (9)
Maine (9)
Maryland (181)
Massachusetts (1108)
Michigan (70)
Minnesota (95)
Mississippi (1)
Missouri (15)
Montana (3)
Nevada (16)
New Hampshire (9)
New Jersey (587)
New Mexico (5)
New York (487)
North Carolina (175)
North Dakota (2)
Northern California (1005)
Ohio (38)
Oklahoma (1)
Oregon (2)
Pennsylvania (349)
Rhode Island (2)
South America (84)
South Carolina (2)
Southern California (637)
Tennessee (12)
Texas (231)
United States (6194)
Utah (63)
Virginia (26)
Washington D.C. (4)
Washington State (174)
West Virginia (1)
Wisconsin (17)
73,012 Results for "71".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The $71 Billion Cancer Shift: Why The FDA Is Speeding Up
February 5, 2026
·
10 min read
Press Releases
Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval
March 4, 2026
·
4 min read
Press Releases
Humanetics Corporation to Present at Radiation Research Society 71st Annual International Meeting
September 10, 2025
·
1 min read
Press Releases
Viral Vector and Plasmid DNA Manufacturing Market Size to Surpass USD 40.71 Billion by 2034
September 22, 2025
·
1 min read
Psychedelics
Cybin’s Small Depression Study Shows 71% Remission Rate
Phase II results for Cybin’s psilocin therapy showed remission rates of 71%, but just eight patients made it to the 12-month milestone.
November 18, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
High Potency Active Pharmaceutical Ingredients Market Poised for Growth, Expected to Hit USD 71.39 Billion by 2032-Coherent Market Insights
November 3, 2025
·
1 min read
Press Releases
Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
December 11, 2025
·
11 min read
Press Releases
Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program
October 3, 2025
·
5 min read
Press Releases
NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth
October 31, 2025
·
8 min read
Press Releases
Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
October 3, 2025
·
9 min read
1 of 7,302
Next
